Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Journal of Women'S Health (2002)|February 28, 2020
Sex-Based Differences in Melanoma Survival in a Contemporary Patient CohortTina J Hieken, Amy E Glasgow, Elizabeth Ann L Enninga, et al.
Frontiers in Oncology|November 3, 2025
Case Report: Complete pathologic response in advanced melanoma with SFRT and dual checkpoint inhibitionJared Hobson, Michael P Grams, Joanina K Gicobi, et al.
Melanoma Research|November 27, 2014
Impact of BRAF mutation and BRAF inhibition on melanoma brain metastasesTulasi Gummadi, Ben Y Zhang, Sara Valpione, et al.
Cancer|December 13, 2005
Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanomaRavi D Rao, Shernan G Holtan, James N Ingle, et al.
Melanoma Research|June 24, 2011
Pilot study of granulocyte-macrophage colony-stimulating factor and interleukin-2 as immune adjuvants for a melanoma peptide vaccineMatthew S Block, Vera J Suman, Wendy K Nevala, et al.
Melanoma Research|May 2, 2015
Ipilimumab-induced colitis in patients with metastatic melanomaKara M De Felice, Arjun Gupta, Sagar Rakshit, et al.
Melanoma Research|March 16, 2017
Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanomaRoberto A Leon-Ferre, Lisa A Kottschade, Matthew S Block, et al.
Cancer|April 8, 2011
A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group Study, N057E(1)Lisa A Kottschade, Vera J Suman, Thomas Amatruda, et al.
Cancer|December 18, 2008
Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047ADomingo G Perez, Vera J Suman, Tom R Fitch, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 12, 2010
The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trialLisa A Kottschade, Jeff A Sloan, Miroslaw A Mazurczak, et al.
Pageof 7